Prescription Drug Information: Sodium Bicarbonate (Page 2 of 2)

HOW SUPPLIED

Sodium Bicarbonate Injection, USP is supplied in the following dosage forms:

List No.

Dosage Form

Conc. %

mg/mL (NaHCO3 )

mEq/mL (Na+)

mEq/mL (HCO3 )

mEq/Container size (mL)

mOsmol

pH

6637 6625 4900 4916 1594 5534

Abboject® Syringe Fliptop Vial Abboject® Syringe (Pediatric) Abboject® Syringe LVP Glass Container Abboject® Syringe (Infant)

8.4 8.4 8.4 7.5 5.0 4.2

84 84 84 75 50 42

1.0 1.0 1.0 0.9 0.6 0.5

1.0 1.0 1.0 0.9 0.6 0.5

50/50 50/50 10/10 44.6/50 297.5/500 5/10

2/mL 2/mL 2/mL 1.79/mL 1190/liter 1/mL

8.0 (7.0 to 8.5) 7.8 (7.0 to 8.5) 8.0 (7.0 to 8.5) 8.0 (7.0 to 8.5) 7.8 (7.0 to 8.5) 8.0 (7.0 to 8.5)

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Revised: October, 2005

©Hospira 2005 EN-1064 Printed in USA

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

ABBOJECT® is a trademark of the Abbott group of companies.

PRINCIPAL DISPLAY PANEL — 50 mL Vial Label

50 mL Single-dose

8.4% Sodium
Bicarbonate
Inj., USP
Rx only

50 mEq (1 mEq/mL)4.2 grams (84 mg/mL)

HOSPIRA, INC., LAKE FOREST, IL 60045 USA

PRINCIPAL DISPLAY PANEL -- 50 mL Vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL Vial Tray

50 mL Single-dose
25 Units/NDC 0409-6625-02
Rx only

8.4% Sodium Bicarbonate
Injection, USP

50 mEq (1 mEq/mL)
4.2 grams (84 mg/mL)Hospira

PRINCIPAL DISPLAY PANEL -- 50 mL Vial Tray
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL Syringe Label — 6637

50 mL Single-dose
NDC 0409-6637-34

8.4% SODIUM BICARBONATE
Injection, USP
50 mEq (1 mEq/mL)
Rx only

For I.V. use. Usual dosage: See insert. Sterile, nonpyrogenic.
Discard unused portion.
2 mOsmol/mL (calc.).pH 8.0 (7.0 to 8.5).

RL-0053 (4/04)

PRINCIPAL DISPLAY PANEL -- 50 mL Syringe Label -- 6637
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL Syringe Carton — 6637

50 mL
NDC 0409-6637-34

8.4% Sodium
Bicarbonate
Injection, USP
50 mEq
(1 mEq/mL)

LifeShield™

Glass
ABBOJECT™
Unit of Use Syringe

with male luer lock
adapter and 18-Gauge
protected needle

Rx only

Hospira◀ PUSH AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL -- 50 mL Syringe Carton -- 6637
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mL Syringe Label — 4900

10 mL Single-dose
NDC 0409-4900-34

PEDIATRIC
8.4% SODIUM BICARBONATE
Inj., USP 10 mEq (1 mEq/mL)

Rx only

Hospira

For I.V. use. Usual dosage: See insert. Sterile,
nonpyrogenic. 2 mOsmol/mL (calc.). pH 8.0 (7.0 to 8.5).

Hospira, Inc., Lake Forest, IL 60045 USARL-0047 (4/04)

PRINCIPAL DISPLAY PANEL -- 10 mL Syringe Label -- 4900
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mL Syringe Carton — 4900

10 mL
NDC 0409-4900-34

PEDIATRIC
8.4% SODIUM
BICARBONATE
INJ., USP
10 mEq (1 mEq/mL)

LifeShield™

Glass
ABBOJECT™
Unit of Use Syringe

with male luer lock
adapter and 20-Gaugeprotected needle

8.4%

Rx only

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL -- 10 mL Syringe Carton -- 4900
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL Syringe Label — 4916

50 mL Single-dose
NDC 0409-4916-34

7.5% SODIUM BICARBONATE
Injection, USP
44.6 mEq (0.9 mEq/mL)
Rx only

For I.V. use. Usual dosage: See insert. Sterile, nonpyrogenic. Discard
unused portion.
1.79 mOsmol/mL (calc.).pH 8.0 (7.0 to 8.5)

RL-0056 (4/04)

PRINCIPAL DISPLAY PANEL -- 50 mL Syringe Label -- 4916
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 50 mL Syringe Carton — 4916

50 mL
NDC 0409-4916-34

7.5% SODIUM
BICARBONATE
Inj., USP
44.6 mEq
(0.9 mEq/mL)

LifeShield™

Glass
ABBOJECT®
Unit of Use Syringe

with male luer lock
adapter and 18-Gaugeprotected needle

Rx only

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL -- 50 mL Syringe Carton -- 4916
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mL Syringe Label — 5534

10 mL Single-dose
NDC 0409-5534-34

4.2% Sodium Bicarbonate Inj., USP

5 mEq/10 mL (0.5 mEq/mL)
Rx only

For intravenous use.
Usual dosage: See insert. Sterile, nonpyrogenic.
0.84 mOsmol/mL. pH 8.0 (7.0 to 8.5).

Hospira, Inc., Lake Forest, IL 60045 USARL — 6947

PRINCIPAL DISPLAY PANEL -- 10 mL Syringe Label -- 5534
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mL Syringe Carton — 5534

10 mL
NDC 0409-5534-34
Rx only

4.2%
Sodium
Bicarbonate
Injection, USP
5 mEq/10 mL (0.5 mEq/mL)

Glass
ABBOJECT®
Unit of Use Syringe
For intravenous use

with male luer lock adapter and20-Gauge protected needle

Hospira

◀ PRESS AND PULL TO OPEN

PRINCIPAL DISPLAY PANEL -- 10 mL Syringe Carton -- 5534
(click image for full-size original)
SODIUM BICARBONATE sodium bicarbonate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-6625
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM BICARBONATE (BICARBONATE ION and SODIUM CATION) SODIUM BICARBONATE 84 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-6625-02 25 VIAL in 1 TRAY contains a VIAL
1 50 mL in 1 VIAL This package is contained within the TRAY (0409-6625-02)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 03/31/2005 03/01/2022
SODIUM BICARBONATE sodium bicarbonate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-6637
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM BICARBONATE (BICARBONATE ION and SODIUM CATION) SODIUM BICARBONATE 84 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-6637-34 10 CARTON in 1 PACKAGE contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the PACKAGE (0409-6637-34) and contains a SYRINGE
1 50 mL in 1 SYRINGE This package is contained within a CARTON and a PACKAGE (0409-6637-34)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 01/17/2006 04/01/2022
SODIUM BICARBONATE sodium bicarbonate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-4900
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM BICARBONATE (BICARBONATE ION and SODIUM CATION) SODIUM BICARBONATE 84 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-4900-34 10 CARTON in 1 PACKAGE contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the PACKAGE (0409-4900-34) and contains a SYRINGE
1 10 mL in 1 SYRINGE This package is contained within a CARTON and a PACKAGE (0409-4900-34)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 02/21/2006 08/01/2021
SODIUM BICARBONATE sodium bicarbonate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-4916
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM BICARBONATE (BICARBONATE ION and SODIUM CATION) SODIUM BICARBONATE 75 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-4916-34 10 CARTON in 1 PACKAGE contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the PACKAGE (0409-4916-34) and contains a SYRINGE
1 50 mL in 1 SYRINGE This package is contained within a CARTON and a PACKAGE (0409-4916-34)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 02/16/2006 02/01/2022
SODIUM BICARBONATE sodium bicarbonate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0409-5534
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SODIUM BICARBONATE (BICARBONATE ION and SODIUM CATION) SODIUM BICARBONATE 42 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0409-5534-34 10 CARTON in 1 PACKAGE contains a CARTON
1 1 SYRINGE in 1 CARTON This package is contained within the PACKAGE (0409-5534-34) and contains a SYRINGE
1 10 mL in 1 SYRINGE This package is contained within a CARTON and a PACKAGE (0409-5534-34)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 12/12/2005 05/01/2022
Labeler — Hospira, Inc. (141588017)
Establishment
Name Address ID/FEI Operations
Hospira, Inc. 093132819 ANALYSIS (0409-4900), ANALYSIS (0409-4916), ANALYSIS (0409-5534), ANALYSIS (0409-6625), ANALYSIS (0409-6637), MANUFACTURE (0409-4900), MANUFACTURE (0409-4916), MANUFACTURE (0409-5534), MANUFACTURE (0409-6625), MANUFACTURE (0409-6637), PACK (0409-4900), PACK (0409-4916), PACK (0409-5534), PACK (0409-6625), PACK (0409-6637), LABEL (0409-4900), LABEL (0409-4916), LABEL (0409-5534), LABEL (0409-6625), LABEL (0409-6637)

Revised: 11/2021 Hospira, Inc.

Page 2 of 2 1 2

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.